We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Wearable Rapid Gas Analyzer Could Detect Illness Immediately

By LabMedica International staff writers
Posted on 08 Aug 2022

Advancements in micro-gas chromatography in the past 20 years have demonstrated great potential for the development of powerful portable gas analysis devices. More...

But it remains a challenge to achieve efficient separation and rapid detection for effective gas analysis in a highly integrated and cost-effective platform, as well as in a mobile device. Now, researchers are creating a portable, wearable device for rapid gas analysis that could detect illness immediately.

The device being created by electrical engineering researchers at The University of Texas at Arlington (Arlington, TX, USA) will play an important role in health care, among other sectors. The project will create technology to transform a powerful gas analysis instrument traditionally used in research labs into portable and wearable devices that are easily accepted and accessible by the public. The project has received a USD 550,000 National Science Foundation (NSF) grant from the Partnerships for Innovation–Research Partnerships program, which aims to take devices developed in the laboratory to the marketplace more quickly.

The vast applications could propel the device to the marketplace more quickly. In health care, the device could analyze a person’s breath samples to find chemical markers that are specifically linked to infections, cancers and other health conditions. In turn, that could lead to a convenient and rapid health screening and monitoring tool to be used at home.

“The key to the project is system-level integration, including creating new micro-gas chromatography architecture and using photonic integrated circuits to achieve rapid and comprehensive volatile organic compounds gas analysis,” said Yuze “Alice” Sun, an associate professor in the Department of Electrical Engineering, who is the principal investigator on the project.

“Not only does the project have the potential of improving our lives, but it could take up so much less space than current chromatography analysis machines,” said Diane Huffaker, chair and professor of electrical engineering. “This could save an enormous amount of testing time, too.”

Related Links:
The University of Texas at Arlington 


Gold Member
Automated MALDI-TOF MS System
EXS 3000
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Clinical Chemistry System
P780
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: Development of targeted therapeutics and diagnostics for extrapulmonary tuberculosis at University Hospital Cologne (Photo courtesy of Michael Wodak/Uniklinik Köln)

Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis

Extrapulmonary tuberculosis (EPTB) remains difficult to diagnose and treat because it spreads beyond the lungs and lacks easily accessible biomarkers. Despite TB infecting 10 million people yearly, the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.